Antiandrogen/castration may reduce death risk by 20%

New Orleans--Bicalutamide (Casodex), 50 mg, plus castration leads to an estimated 20% reduction in risk of prostate cancer death versus castration alone, according to results of a historical data analysis presented at the annual of the American Society of Clinical Oncology meeting here.

Related Videos

Related Content

Advertisement

February 4th 2025

FDA Updates in Urology: January 2025

Patrick Campbell

A recap of the FDA submissions and regulatory decisions in urology from January 2025.

January 29th 2025

Identifying Patients with Intermediate Risk in NMIBC

Max Kates, MD Neal Shore, MD, FACS Tom Jayram, MD

Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.

February 4th 2025

Urologic Cancer Facts and Updates for World Cancer Day 2025

Patrick Campbell

A list of facts and trends to know about the current landscape of urologic cancer management and research in the US.

January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

February 3rd 2025

AI and wearables: The new age of smart sex

Dayna R. Smerina Amy M. Pearlman, MD

"Wearable devices are increasingly being used to understand and improve male sexual dysfunctions," write the authors.

February 3rd 2025

Hundreds of future urologists celebrate Urology Match Day 2025

Hannah Clarke

Overall, 403 medical students and other applicants were matched across 148 urology residency programs nationwide.

Related Content

Advertisement

February 4th 2025

FDA Updates in Urology: January 2025

Patrick Campbell

A recap of the FDA submissions and regulatory decisions in urology from January 2025.

January 29th 2025

Identifying Patients with Intermediate Risk in NMIBC

Max Kates, MD Neal Shore, MD, FACS Tom Jayram, MD

Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.

February 4th 2025

Urologic Cancer Facts and Updates for World Cancer Day 2025

Patrick Campbell

A list of facts and trends to know about the current landscape of urologic cancer management and research in the US.

January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

February 3rd 2025

AI and wearables: The new age of smart sex

Dayna R. Smerina Amy M. Pearlman, MD

"Wearable devices are increasingly being used to understand and improve male sexual dysfunctions," write the authors.

February 3rd 2025

Hundreds of future urologists celebrate Urology Match Day 2025

Hannah Clarke

Overall, 403 medical students and other applicants were matched across 148 urology residency programs nationwide.